Cargando…
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy
OBJECTIVE: To examine the imaging-detected mechanism of reduction of structural joint damage progression by tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) using MRI. METHODS: In a substudy of a randomised, double-blind, phase 3b study (ACT-RAY) of biologic-naïve patients with RA who we...
Autores principales: | Conaghan, Philip G, Peterfy, Charles, Olech, Ewa, Kaine, Jeffrey, Ridley, David, DiCarlo, Julie, Friedman, Josh, Devenport, Jenny, Troum, Orrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995246/ https://www.ncbi.nlm.nih.gov/pubmed/24525910 http://dx.doi.org/10.1136/annrheumdis-2013-204762 |
Ejemplares similares
-
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
por: Conaghan, Philip G, et al.
Publicado: (2013) -
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
por: Huizinga, T W J, et al.
Publicado: (2015) -
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
por: Dougados, Maxime, et al.
Publicado: (2014) -
SAPHO Syndrome: Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis
por: Hagiwara, Kiyofumi, et al.
Publicado: (2017) -
Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update
por: Liu, Shuang, et al.
Publicado: (2020)